Comparison of Duodenal Stenting vs Transpyloric and Duodenal Stenting for Malignant Obstruction
NCT ID: NCT03125148
Last Updated: 2022-05-27
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2017-05-27
2019-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EUS-GE vs ES for Palliation of Gastric Outlet Obstruction
NCT03259763
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
NCT00004910
Partially Covered Versus Uncovered Pyloro-duodenal Stents for Unresectable Malignant Gastric Outlet Obstruction. A Double Blinded Randomised Controlled Trial.
NCT03223831
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction
NCT00004911
Covered Versus Uncovered Self-expandable Metallic Stents for Malignant Gastric Outlet Obstruction
NCT01646476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enteral stenting intraduodenal
Enteral stent (Wallflex enteral stent) will be placed in the duodenum with the entire stent lying within the duodenum bridging the obstruction.
Enteral stenting
Enteral stent for malignant duodenal obstruction
Enteral stenting transpyloric
Enteral stent (Wallflex enteral stent) will be placed in the duodenum with the stent bridging the obstruction and the pyloric opening with proximal end of the stent lying within the stomach
Enteral stenting
Enteral stent for malignant duodenal obstruction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enteral stenting
Enteral stent for malignant duodenal obstruction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2\. Evidence of a single small bowel obstruction
3\. Considered palliative (can be on narcotics, chemotherapy, and/or radiation therapy)
4\. Not a surgical candidate
5\. \>18 years of age
6\. Able to give consent
7\. Eligible for endoscopy (medically fit)
8\. Able to traverse past obstruction with a guidewire
Exclusion Criteria
2\. Unable to give consent
3\. Pregnant
4\. Have evidence of multiple sites of obstruction in the small bowel
5\. Have evidence of duodenal obstruction secondary to gastric cancer
6\. Ineligible for endoscopy (due to comorbidities or acuity of illness)
7\. Unable to traverse past obstruction with a guidewire
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical College of Wisconsin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kulwinder Dua, MD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Rusch, PhD
Role: STUDY_CHAIR
Medical College of Wisconsin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Froedtert Hospital
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO00028657
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.